Somewhat Positive Press Coverage Somewhat Unlikely to Affect Harte-Hanks (HHS) Stock Price

News headlines about Harte-Hanks (NYSE:HHS) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Harte-Hanks earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the business services provider an impact score of 46.0657849268086 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Harte-Hanks (HHS) remained flat at $$1.04 during trading on Tuesday. The stock had a trading volume of 52,300 shares, compared to its average volume of 107,966. Harte-Hanks has a twelve month low of $0.73 and a twelve month high of $1.65. The company has a quick ratio of 1.69, a current ratio of 1.70 and a debt-to-equity ratio of -1.88.

Harte-Hanks (NYSE:HHS) last posted its earnings results on Wednesday, November 8th. The business services provider reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.03). The business had revenue of $94.42 million during the quarter, compared to the consensus estimate of $95.20 million. Harte-Hanks had a negative return on equity of 152.65% and a negative net margin of 33.12%. research analysts anticipate that Harte-Hanks will post -0.19 earnings per share for the current year.

HHS has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Harte-Hanks from a “sell” rating to a “buy” rating and set a $1.25 target price for the company in a research report on Monday. Noble Financial reiterated a “buy” rating on shares of Harte-Hanks in a research note on Monday, November 27th.

ILLEGAL ACTIVITY WARNING: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2017/12/05/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-harte-hanks-hhs-stock-price.html.

Harte-Hanks Company Profile

Harte Hanks, Inc (Harte Hanks) is a multi-channel marketing company. The Company’s Customer Interaction business offers a range of marketing services, in media from direct mail to e-mail, including agency and digital services; database marketing solutions and business-to-business lead generation; direct mail, and contact centers.

Insider Buying and Selling by Quarter for Harte-Hanks (NYSE:HHS)

Receive News & Ratings for Harte-Hanks Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte-Hanks Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply